Lil Wayne Performs Halftime Show in Hit Mobile Game Clash Royale 9-02-2026, 20:15

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26

Kadant to Hold Earnings Conference Call on Thursday, 11-02-2023, 04:09